Staphylococcus lugdunensis strain with a modified PBP1A/1B expressing resistance to β-lactams

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 2, 2012, Pages 169-172

  Kotsakis, S D ^a,b   Tzouvelekis, L S ^b,c   Zerva, L ^d   Liakopoulos, A ^a   Petinaki, E ^a  

^a UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^b HELLENIC PASTEUR INSTITUTE   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; APOENZYME; BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; DAPTOMYCIN; GENTAMICIN; LINEZOLID; OXACILLIN; PBP1A APOENZYME; PBP1B APOENZYME; PENICILLIN G; PSEUDOMONIC ACID; TEICOPLANIN; TETRACYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; CONTROLLED STUDY; FTSI GENE; MECA GENE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PBP1A GENE; PBP1B GENE; PBP4 GENE; PENICILLIN AMIDASE V GENE; PRIORITY JOURNAL; STAPHYLOCOCCUS LUGDUNENSIS;

AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; ENDOCARDITIS, BACTERIAL; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PENICILLIN-BINDING PROTEINS; PEPTIDYL TRANSFERASES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS LUGDUNENSIS;

EID: 84857044595     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1289-8     Document Type: Article

References (16)

1. KL Frank JL del Pozo R Patel 2008 From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis Clin Microbiol Rev 21 111 133 18202439 10.1128/CMR.00036-07 1:CAS:528: DC%2BD1cXitlGrtL0%3D (Pubitemid 351160012)
2. Clinical and Laboratory Standards Institute (CLSI) (2009) Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement, 10th edn. Approved standard M100-S19. CLSI, Wayne, PA
3. CA Wood RM Wisniewski 1994 Beta-lactams versus glycopeptides in treatment of subcutaneous abscesses infected with Staphylococcus aureus Antimicrob Agents Chemother 38 1023 1026 8067732 1:CAS:528:DyaK2cXjtFGhtLw%3D (Pubitemid 24150832)
4. E Petinaki V Miriagou LS Tzouvelekis F Hatzi NJ Legakis AN Maniatis 2002 Evaluation of an anti-PBP 2a slide latex agglutination test in coagulase-negative staphylococci isolated in Greek hospitals Diagn Microbiol Infect Dis 42 4 279 282 12007447 10.1016/S0732-8893(01)00362-5 1:CAS:528:DC%2BD38Xjtl2ns7s%3D (Pubitemid 34455020)
5. KS Chatzigeorgiou C Ikonomopoulou S Kalogeropoulou N Siafakas G Giannopoulos A Antoniadou, et al. 2010 Two successfully treated cases of Staphylococcus lugdunensis endocarditis Diagn Microbiol Infect Dis 68 445 448 21094427 10.1016/j.diagmicrobio.2010.07.018
6. N Eswar D Eramian B Webb MY Shen A Sali 2008 Protein structure modeling with MODELLER Methods Mol Biol 426 145 159 18542861 10.1007/978-1-60327-058-8-8 1:CAS:528:DC%2BD1cXktlKqsrg%3D
7. AL Lovering L De Castro NC Strynadka 2008 Identification of dynamic structural motifs involved in peptidoglycan glycosyltransfer J Mol Biol 383 167 177 18760285 10.1016/j.jmb.2008.08.020 1:CAS:528:DC%2BD1cXhtFeksbbF
8. SD Kotsakis V Miriagou E Tzelepi LS Tzouvelekis 2010 Comparative biochemical and computational study of the role of naturally occurring mutations at Ambler positions 104 and 170 in GES β-lactamases Antimicrob Agents Chemother 54 4864 4871 20696873 10.1128/AAC.00771-10 1:CAS:528: DC%2BC3cXhsVCitrvN
9. MY Shen A Sali 2006 Statistical potential for assessment and prediction of protein structures Protein Sci 15 2507 2524 17075131 10.1110/ps.062416606 1:CAS:528:DC%2BD28XhtFygsrfO (Pubitemid 44771688)
10. RA Laskowski MW MacArthur DS Moss JM Thornton 1993 PROCHECK: a program to check the stereochemical quality of protein structures J Appl Cryst 26 283 291 10.1107/S0021889892009944 1:CAS:528:DyaK3sXit12lurY%3D
11. D van der Spoel E Lindahl B Hess G Groenhof AE Mark HJC Berendsen 2005 GROMACS: fast, flexible, and free J Comput Chem 26 1701 1718 10.1002/jcc.20291 (Pubitemid 43076182)
12. EJ Sorin VS Pande 2005 Exploring the helix-coil transition via all-atom equilibrium ensemble simulations Biophys J 88 2472 2493 15665128 10.1529/biophysj.104.051938 1:CAS:528:DC%2BD2MXjtFCjsL0%3D (Pubitemid 40976118)
13. CJ Hackbarth T Kocagoz S Kocagoz HF Chambers 1995 Point mutations in Staphylococcus aureus PBP 2 gene affect penicillin-binding kinetics and are associated with resistance Antimicrob Agents Chemother 39 103 106 7695289 1:CAS:528:DyaK2MXislKks7c%3D
14. E Petinaki G Dimitracopoulos I Spiliopoulou 2001 Decreased affinity of PBP3 to methicillin in a clinical isolate of Staphylococcus epidermidis with borderline resistance to methicillin and free of the mecA gene Microb Drug Resist 7 3 297 300 11759092 10.1089/10766290152652855 1:CAS:528: DC%2BD3MXpt1Wjt7Y%3D (Pubitemid 33104605)
15. E Petinaki A Arvaniti C Bartzavali G Dimitracopoulos I Spiliopoulou 2002 Presence of mec genes and overproduction of beta-lactamase in the expression of low-level methicillin resistance among staphylococci Chemotherapy 48 4 174 181 12218264 10.1159/000063871 1:CAS:528:DC%2BD38XmvFWgt7g%3D
16. C Fuda M Suvorov SB Vakulenko S Mobashery 2004 The basis for resistance to beta-lactam antibiotics by penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus J Biol Chem 279 4802 4806 10.1074/jbc.M403589200 (Pubitemid 39287677)